Latest Pluripotency Stories
Residual "memory" of the tissue of origin makes it harder to turn them into other cell types BOSTON, July 19 /PRNewswire-USNewswire/ -- Adult cells that have been reprogrammed into induced pluripotent stem cells (iPS cells) do not completely let go of their past, perhaps limiting their ability to function as a less controversial alternative to embryonic stem cells for basic research and cell replacement therapies, according to researchers at Children's Hospital Boston, John Hopkins University...
A team from the University of Nottingham has been using a Mexican aquatic salamander called an axolotl to study the evolution and genetics of stem cells - research that supports the development of regenerative medicine to treat the consequences of disease and injury using stem cell therapies.
Cells from frozen human blood samples can be reprogrammed to an embryonic stem-cell-like state.
Stored samples of frozen blood can be used to make cells that resemble stem cells, potentially creating a new and easier source for the valued cells, researchers said on Thursday.
SAN DIEGO and OTTAWA, Canada, June 28 /PRNewswire/ -- Fate Therapeutics, Inc. announced today that the Company received Red Herring's North America 100 award, a prestigious list honoring the year's most promising private and innovative companies from the North American business region.
The therapeutic potential of embryonic stem cells has been an intense focus of study and discussion in biomedical research and has resulted in technologies to produce human induced pluripotent stem cells (hiPSCs).
BETHESDA, Md., June 15 /PRNewswire-USNewswire/ -- The Federation of American Societies for Experimental Biology (FASEB) is pleased to announce that Gail R.
SOUTH SAN FRANCISCO, Calif., June 15 /PRNewswire/ -- iPierian, Inc., the leading biopharmaceutical company focused on creating new therapeutics using patient-derived induced pluripotent stem cells (iPSCs), today announced that it will present data from its iPSC research programs at the International Society for Stem Cell Research (ISSCR) 8th Annual Meeting, June 16-19, 2010, in San Francisco, CA.
COSTA MESA, Calif., June 14 /PRNewswire/ -- DV Biologics LLC announced today that it has executed an agreement with System Biosciences LLC for the development of human-derived disease-specific induced pluripotent stem cell (iPSC) lines. iPSCs are pluripotent cells which are developed from non-pluripotent cells that have undergone gene expression changes to render them pluripotent giving them the ability to then form many different cell types. iPSCs offer an exceedingly-powerful approach to...
Researchers at Mount Sinai School of Medicine have for the first time differentiated human stem cells to become heart cells with cardiomyopathy, a condition in which the heart muscle cells are abnormal.
- totally perplexed and mixed up.